Literature DB >> 19276661

Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissues.

Changqing Ma1, Kelly M Quesnelle, Anthony Sparano, Shilpa Rao, Min S Park, Marc A Cohen, Yan Wang, Minu Samanta, Madhu S Kumar, M Usman Aziz, Tara L Naylor, Barbara L Weber, Steven S Fakharzadeh, Gregory S Weinstein, Anil Vachani, Michael D Feldman, Marcia S Brose.   

Abstract

The Cub and Sushi Multiple Domains-1 (CSMD1) is a tumor suppressor gene on 8p23.2, where allelic loss is both frequent and associated with poor prognosis in head and neck squamous cell carcinoma (HNSCC). To understand the extent of CSMD1 aberrations in vivo, we characterized 184 primary tumors from the head and neck, lung, breast and skin for gene copy number and analyzed expression in our HNSCCs and lung squamous cell carcinomas (SCCs). We detected loss of CSMD1 in a large proportion of HNSCCs (50%), lung (46%) and breast cancers (55%), and to a lesser extent in cutaneous SCCs (29%) and basal cell carcinomas (BCCs, 17%) using array-based comparative genomic hybridization (aCGH). Studying the region more closely with quantitative real-time PCR (qPCR), the loss of CSMD1 increased to 80% in HNSCCs and 93% in lung SCCs. CSMD1 expression was decreased in tumors compared to adjacent benign tissue (65%, 13/20) and was likely due to gene loss in 45% of cases (9/20). We also identified truncated transcripts lacking exons due to DNA copy number loss (30%, 5/17) or aberrant splicing (24%, 4/17). We show loss of CSMD1 in primary HNSCC tissues, and document for the first time that CSMD1 is lost in breast, lung and cutaneous SCCs. We also show that deletions of CSMD1 and aberrant splicing contribute to altered CSMD1 function in vivo.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19276661     DOI: 10.4161/cbt.8.10.8132

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  40 in total

1.  Identification of novel candidate gene loci and increased sex chromosome aneuploidy among infants with conotruncal heart defects.

Authors:  Kazutoyo Osoegawa; David M Iovannisci; Bin Lin; Christina Parodi; Kathleen Schultz; Gary M Shaw; Edward J Lammer
Journal:  Am J Med Genet A       Date:  2013-10-11       Impact factor: 2.802

2.  Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients.

Authors:  Rui Zhang; Chun Song
Journal:  Tumour Biol       Date:  2014-01-10

3.  Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies.

Authors:  Laura E Hogan; Julia A Meyer; Jun Yang; Jinhua Wang; Nicholas Wong; Wenjian Yang; Gregory Condos; Stephen P Hunger; Elizabeth Raetz; Richard Saffery; Mary V Relling; Deepa Bhojwani; Debra J Morrison; William L Carroll
Journal:  Blood       Date:  2011-09-14       Impact factor: 22.113

4.  Comprehensive Genetic Landscape of Uveal Melanoma by Whole-Genome Sequencing.

Authors:  Beryl Royer-Bertrand; Matteo Torsello; Donata Rimoldi; Ikram El Zaoui; Katarina Cisarova; Rosanna Pescini-Gobert; Franck Raynaud; Leonidas Zografos; Ann Schalenbourg; Daniel Speiser; Michael Nicolas; Laureen Vallat; Robert Klein; Serge Leyvraz; Giovanni Ciriello; Nicolò Riggi; Alexandre P Moulin; Carlo Rivolta
Journal:  Am J Hum Genet       Date:  2016-10-13       Impact factor: 11.025

5.  Clinical and Genetic Factors Associated with Cutaneous Squamous Cell Carcinoma in Kidney and Heart Transplant Recipients.

Authors:  M Lee Sanders; Jason H Karnes; Josh C Denny; Dan M Roden; T Alp Ikizler; Kelly A Birdwell
Journal:  Transplant Direct       Date:  2015-05

6.  Evaluation of microsatellite variation in the 1000 Genomes Project pilot studies is indicative of the quality and utility of the raw data and alignments.

Authors:  L J McIver; J W Fondon; M A Skinner; H R Garner
Journal:  Genomics       Date:  2011-01-09       Impact factor: 5.736

7.  The relationship between EGFR gain and VHL loss in lung adenocarcinoma and poor patient survival.

Authors:  Yushi Zhao; Ye Li; Shengfa Wang; Hongguang Lu; Jianxin Chen; Zhijie Zhang; Yubin Jin; Zhong-Zheng Zhu
Journal:  Int J Clin Oncol       Date:  2011-05-11       Impact factor: 3.402

8.  Comparative oncogenomics identifies tyrosine kinase FES as a tumor suppressor in melanoma.

Authors:  Michael Olvedy; Julie C Tisserand; Flavie Luciani; Bram Boeckx; Jasper Wouters; Sophie Lopez; Florian Rambow; Sara Aibar; Bernard Thienpont; Jasmine Barra; Corinna Köhler; Enrico Radaelli; Sophie Tartare-Deckert; Stein Aerts; Patrice Dubreuil; Joost J van den Oord; Diether Lambrechts; Paulo De Sepulveda; Jean-Christophe Marine
Journal:  J Clin Invest       Date:  2017-05-02       Impact factor: 14.808

9.  Genome-wide association study identifies BICD1 as a susceptibility gene for emphysema.

Authors:  Xiangyang Kong; Michael H Cho; Wayne Anderson; Harvey O Coxson; Nestor Muller; George Washko; Eric A Hoffman; Per Bakke; Amund Gulsvik; David A Lomas; Edwin K Silverman; Sreekumar G Pillai
Journal:  Am J Respir Crit Care Med       Date:  2010-08-13       Impact factor: 21.405

10.  Quantification of read species behavior within whole genome sequencing of cancer genomes for the stratification and visualization of genomic variation.

Authors:  Dror Hibsh; Kenneth H Buetow; Gur Yaari; Sol Efroni
Journal:  Nucleic Acids Res       Date:  2016-01-24       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.